Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 8;13(16):3999. doi: 10.3390/cancers13163999

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Potential inferred metagenomics signatures of therapeutic response in EOC patients receiving neoadjuvant or adjuvant chemotherapy. Differentially represented inferred functions between platinum-sensitive (i.e., PS) and platinum-resistant (i.e., PR) EOC patients receiving neoadjuvant (A) or adjuvant (B) chemotherapy were identified by linear discriminant analysis (LDA) effect size (LEfSe) analysis. The logarithmic threshold for discriminative features was set to 2.0. See also Table S1 for MetaCyc pathways and corresponding superclasses.